Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Succinate dehydrogenase [ubiquinone] iron-sulfur subunit (SDHB) is a nuclear-encoded component of the mitochondrial respiratory chain complex II, which serves as a vital link between the citric acid cycle and the electron transport chain. It functions by facilitating the transfer of electrons from succinate-derived FADH2 to ubiquinone through its three distinct iron-sulfur clusters (UniProt: P21912). Beyond its fundamental role in energy production, SDHB is recognized as a potent tumor suppressor; germline mutations in this subunit are a primary cause of hereditary paraganglioma-pheochromocytoma syndromes (PubMed: 11823443). Loss of SDHB function leads to the pathological accumulation of succinate, an oncometabolite that inhibits alpha-ketoglutarate-dependent dioxygenases, thereby promoting angiogenesis and epigenetic dysregulation (PubMed: 15660115). In the pharmaceutical context, while SDHB is a major target for agricultural fungicides known as SDHIs, it is increasingly investigated in human medicine as a biomarker for SDH-deficient cancers, including specific subtypes of gastrointestinal stromal tumors and renal cell carcinomas (PubMed: 21893128). Therapeutic strategies currently focus on exploiting the metabolic dependencies created by SDHB deficiency or identifying small molecules that can modulate mitochondrial respiration in metabolic diseases (PubMed: 28605213).
Inhibition of the succinate binding site or the ubiquinone binding site within the mitochondrial respiratory chain complex II, preventing electron transfer and succinate oxidation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Succinate dehydrogenase [ubiquinone] iron-sulfur subunit (SDHB).